AM Replenish Lightly Tinted

AM Replenish Lightly Tinted

Buy on Amazon

As an Amazon Associate we earn from qualifying purchases

Brand:
TiZO
Manufacturer:
Fallene, Ltd.
Country of Origin:
USA
00 votes
Repurchase Rate0%

Quality

Joy

Value for money

Price segment

Description

TIZO® AM Replenish Lightly Tinted is formulated with Zinc Oxide, Ceramides, and powerful Antioxidants (Vitamins C and E). Zinc Oxide protects against UV damage and Ceramides help restore the lipid layer. TIZO® AM Replenish helps prevent future UV damage and aids in the repair of existing damage resulting in long lasting moisturization.

Ingredients

ZINC OXIDE 16.0%, CAPRIC/CAPRYLIC TRIGLYCERIDE, CERAMIDE 3, CYCLOHEXASILOXANE, CYCLOPENTASILOXANE, DIMETHICONE, DIMETHICONE CROSSPOLYMER, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, DIMETHICONOL, IRON OXIDE, HYDROGEN DIMETHICONE, PEG-10 DIMETHICONE, POLYHYDROXYSTEARIC ACID, TETRAHEXYLDECYL ASCORBATE, TOCOPHERYL ACETATE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER

***

Ingredients are subject to change at the manufacturer's discretion. For the most complete and up-to-date list of ingredients, refer to the product packaging.

Most similar products

TIZO2 Facial Primer Non-Tinted

TiZO, TIZO2 Facial Primer Non-Tinted

57.4% ingredient match

Shared: 11 ingredients

Original only:
CAPRIC/CAPRYLIC TRIGLYCERIDE, CERAMIDE 3, IRON OXIDE (+2 more)

Alternative only:
TITANIUM DIOXIDE, ALUMINA, LAURYL PEG/PPG-18/18 METHICONE

0(0)
TIZO3 Facial Primer Tinted

TiZO, TIZO3 Facial Primer Tinted

54.3% ingredient match

Shared: 11 ingredients

Original only:
CAPRIC/CAPRYLIC TRIGLYCERIDE, CERAMIDE 3, IRON OXIDE (+2 more)

Alternative only:
TITANIUM DIOXIDE, ALUMINA, CI 77491 (+1 more)

0(0)
Prime & Defend SPF 30

Société Clinical Skincare, Prime & Defend SPF 30

27.1% ingredient match

Shared: 7 ingredients

Original only:
CAPRIC/CAPRYLIC TRIGLYCERIDE, CERAMIDE 3, CYCLOHEXASILOXANE (+6 more)

Alternative only:
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER, MELANIN, TRIBEHENIN (+7 more)

0(0)

Comments 0